Money Matters, Simplified.
walking deformities
Ampyra, Acorda’s drug for multiple sclerosis, gets FDA nod
Sat, 23/01/2010 - 16:38 by Jamie Anderson
 Rochester, NY, January 23 -- The Food and Drug Administration (FDA) gave its nod to a drug meant for patients suffering from multiple sclerosis (MS) and those who experience difficulties in walking. |